Proteon Pharmaceuticals India – a subsidiary of Proteon Pharmaceuticals SA Poland, will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry. It is engaged in the development of precision biology for microbiome protection to improve animal and human health and eliminating the unnecessary use of antibiotics.
Elaborating the product development strategy, Dr. Ramdas Kambale, Director, Sales, Asia Pacific, Proteon Pharmaceuticals said, “Antibiotics usage in chicken is a big concern for food safety and it is really important to take this forward to stop or minimise the usage of antibiotics and look seriously the bacteriophages as its clear-cut alternative.” He also added that the growing population needed to be fed with a proper protein diet which can be achieved by chicken meat being easily and safely available for sustainable consumption.
You may also like to read: 3 Best poultry feed flocks should be given
Proteon Pharmaceuticals India had recently introduced, BAFASAL+G®, a feed additive that prevents and eliminates salmonella on the poultry farm while keeping the microflora in the gut intact.
Recently, Proteon Pharma participated in the 54th CLFMA (The Compound Feed Manufacturers Association) annual meeting and 62nd National Symposium 2021 for creating awareness about the need for alternative high-quality feed options and how high usage of antibiotics is a big concern for food safety and Antimicrobial Resistance (AMR).
Proteon uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.
(All the facts and information are based on the claims made by Proteon Pharmaceuticals.)
